Rosuvastatin in the Treatment of Rectal Cancer

Summary

This study will evaluate whether the addition of Rosuvastatin to standard chemoradiation therapy for the treatment of locally advanced rectal cancer may improve the pathological response rate and survival compared to standard chemoradiation therapy alone.

Timeline

Start

2015-11

Primary completion

2021-09-24

Completion

2021-09-24

Drugs

Indications